Total medical devices industry deals worth $7.3bn were announced globally for January 2022, with the $1.6bn acquisition of Apria being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 83.6% over the previous month of $44.3bn and a drop of 58.1% when compared with the last 12-month average of $17.34bn.
In terms of number of deals, the sector saw a rise of 4.84% with 195 deals in January 2022 when compared to the last 12-month average of 186 deals.
In value terms, North America led the activity with deals worth $4.7bn in January 2022.
medical devices industry deals in January 2022: Top deals
The top five deals accounted for 57.6% of the overall value during January 2022.
The combined value of the top five deals stood at $4.18bn, against the overall value of $7.3bn recorded for the month.
The top five medical devices industry deals of January 2022 tracked by GlobalData were:
1) Owens & Minor $1.6bn acquisition deal with Apria
2) The $1.26bn private equity of 70% stake in Biofarma by Ardian Holding
3) Sema4 OpCo $623m acquisition deal with GeneDX
4) The $450m acquisition of Triad Life Sciences by ConvaTec Group
5) Casdin Capital and Viking Global Investors $250m private equity deal with Fluidigm
